Divi V - Search Results

1

Predictors of readmissions after head and neck cancer surgery: A national perspective.

Chen MM, Orosco RK, Harris JP, Porter JB, Rosenthal EL, Hara W, Divi V. Chen MM, et al. Among authors: divi v. Oral Oncol. 2017 Aug;71:106-112. doi: 10.1016/j.oraloncology.2017.06.010. Oral Oncol. 2017. PMID: 28688676

2

A prospective study of electronic quality of life assessment using tablet devices during and after treatment of head and neck cancers.

Pollom EL, Wang E, Bui TT, Ognibene G, von Eyben R, Divi V, Sunwoo J, Kaplan M, Dimitri Colevas A, Le QT, Hara WY. Pollom EL, et al. Among authors: divi v. Oral Oncol. 2015 Dec;51(12):1132-7. doi: 10.1016/j.oraloncology.2015.10.003. Epub 2015 Oct 23. Oral Oncol. 2015. PMID: 26475062

3

Regional variation in head and neck cancer mortality: Role of patient and hospital characteristics.

Divi V, Ma Y, Rhoads KF. Divi V, et al. Head Neck. 2016 Apr;38 Suppl 1:E1896-902. doi: 10.1002/hed.24343. Epub 2015 Dec 29. Head Neck. 2016. PMID: 26713544

4

Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.

Roberts TJ, Colevas AD, Hara W, Holsinger FC, Oakley-Girvan I, Divi V. Roberts TJ, et al. Among authors: divi v. Cancer. 2016 May 1;122(9):1388-97. doi: 10.1002/cncr.29932. Epub 2016 Mar 11. Cancer. 2016. PMID: 26969807 Free article.

5

Third party assessment of resection margin status in head and neck cancer.

Ransohoff A, Wood D, Solomon Henry A, Divi V, Colevas A. Ransohoff A, et al. Among authors: divi v. Oral Oncol. 2016 Jun;57:27-31. doi: 10.1016/j.oraloncology.2016.03.009. Epub 2016 Apr 12. Oral Oncol. 2016. PMID: 27208841

6

Lymph Node Count From Neck Dissection Predicts Mortality in Head and Neck Cancer.

Divi V, Chen MM, Nussenbaum B, Rhoads KF, Sirjani DB, Holsinger FC, Shah JL, Hara W. Divi V, et al. J Clin Oncol. 2016 Nov 10;34(32):3892-3897. doi: 10.1200/JCO.2016.67.3863. J Clin Oncol. 2016. PMID: 27480149

7

Geographic variation in Medicare treatment costs and outcomes for advanced head and neck cancer.

Divi V, Tao L, Whittemore A, Oakley-Girvan I. Divi V, et al. Oral Oncol. 2016 Oct;61:83-8. doi: 10.1016/j.oraloncology.2016.08.018. Epub 2016 Sep 6. Oral Oncol. 2016. PMID: 27688109

8

Association of Postoperative Radiotherapy With Survival in Patients With N1 Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.

Chen MM, Harris JP, Hara W, Sirjani D, Divi V. Chen MM, et al. Among authors: divi v. JAMA Otolaryngol Head Neck Surg. 2016 Dec 1;142(12):1224-1230. doi: 10.1001/jamaoto.2016.3519. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 27832255

9

Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.

Amoils M, Lee CS, Sunwoo J, Aasi SZ, Hara W, Kim J, Sirjani D, Colevas AD, Chang AL, Divi V. Amoils M, et al. Among authors: divi v. Head Neck. 2017 May;39(5):881-885. doi: 10.1002/hed.24692. Epub 2017 Mar 2. Head Neck. 2017. PMID: 28252823

10

The Multidisciplinary, Function-Oriented Evaluation.

Hara W, Divi V. Hara W, et al. Among authors: divi v. Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):891. doi: 10.1016/j.ijrobp.2016.12.004. Epub 2017 Mar 15. Int J Radiat Oncol Biol Phys. 2017. PMID: 28333007 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters